<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04301193</url>
  </required_header>
  <id_info>
    <org_study_id>84317</org_study_id>
    <nct_id>NCT04301193</nct_id>
  </id_info>
  <brief_title>Evaluation of Novel Point of Care Coagulation System in Pregnant Women</brief_title>
  <acronym>CCPW</acronym>
  <official_title>Evaluation of Novel Point of Care Coagulation System in Pregnant Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland, Baltimore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HemoSonics LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland, Baltimore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators will evaluate a new point of care Quantra Hemostasis Analyzer
      system to assess coagulation rapidly with ease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Unexpected bleeding continues to be an issue that confronts anesthesiologists. Obstetric
      bleeding spearheads as the leading cause of maternal mortality and morbidity. One of the
      hurdles that clinicians confront is a lack of point of care coagulation system that can
      hasten the clinical management strategy in the right direction. Conventional methods take
      considerable time to obtain results. TEG and ROTEM are currently doing the job however these
      two modalities requires expertise and proficient training to perform test and interpret
      results. The level of expertise to run the TEG and ROTEM poses hurdles for providing
      coagulation around the clock as it requires trained operators. What is currently required for
      efficient and effective management of obstetric hemorrhage is a point of care coagulation
      system in the operating room and or labor and delivery suite that is user friendly, easy and
      quick to perform. In this study the investigators will evaluate a new point of care Quantra
      Hemostasis Analyzer system to assess coagulation rapidly with ease.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of coagulation using Quantra system.</measure>
    <time_frame>Baseline</time_frame>
    <description>How Fibrinogen level of the patient is reflected by FCS (Fibrinogen Clot Strength of Quantra)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine how other conventional tests such as PT, PTT, and INR relate to clotting time of Quantra.</measure>
    <time_frame>Baseline</time_frame>
    <description>How PT, PTT, and INR level of the patient is reflected by Clot Strength of Quantra</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hemorrhage</condition>
  <condition>Coagulation Delay</condition>
  <arm_group>
    <arm_group_label>Pregnant Women</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All subjects will have the same intervention. Samples will be taken and manipulated in the laboratory for use of the Hemosonic Qauntra Analyzer</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Quantra Analyzer</intervention_name>
    <description>Subjects blood will be manipulated in the lab and will be tested with the Quantra Analyzer</description>
    <arm_group_label>Pregnant Women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant woman at 37-41 weeks gestation

        Exclusion Criteria:

          -  Hypertension

          -  Preeclampsia

          -  Gestational diabetes

          -  Preexisting coagulopathy

          -  History of deep vein thrombosis (DVT)

          -  Medications that impair coagulation

          -  History of pulmonary embolism or thrombosis

          -  Women in active labor receiving intravenous fluids or oxytocin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bhavani Kodali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland, Baltimore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bhavani Kodali, MD</last_name>
    <phone>410-328-4229</phone>
    <email>bkodali@som.umaryland.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>LaToya Stubbs, MS</last_name>
    <phone>410-328-9951</phone>
    <email>lstubbs@som.umaryland.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Maryland Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bhavani Kodali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>March 5, 2020</last_update_submitted>
  <last_update_submitted_qc>March 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland, Baltimore</investigator_affiliation>
    <investigator_full_name>Bhavani Kodali</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 2, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT04301193/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

